Presentation is loading. Please wait.

Presentation is loading. Please wait.

Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001)  Dorothy A. White, MD, Lawrence.

Similar presentations


Presentation on theme: "Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001)  Dorothy A. White, MD, Lawrence."— Presentation transcript:

1 Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001)  Dorothy A. White, MD, Lawrence H. Schwartz, MD, Sasa Dimitrijevic, PhD, Lilla Di Scala, PhD, Wendy Hayes, Do, Stefan H. Gross, MSc  Journal of Thoracic Oncology  Volume 4, Issue 11, Pages (November 2009) DOI: /JTO.0b013e3181ba20b1 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Probable case. Left, New slight patchy focal infiltrate (Pattern B) on right side—12 weeks. Middle, Worsening focal infiltrate on right side and ground-glass opacities on left side—16 weeks. Right, Bilateral patchy infiltrates/ground-glass opacities—20 weeks (Supplement: case 1). Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20b1) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Probable case. Left top, Baseline—bibasilar interstitial infiltrates (interstitial lung disease). Middle, New ground-glass opacities (pattern A)—4 weeks. Right top, Bibasilar patchy infiltrates (pattern B)—12 weeks. Left bottom, Worsening infiltrates—16 weeks. Right bottom, After dose reduction of everolimus for fatigue improved infiltrates are noted (Supplement: case 3). Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20b1) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Possible case. Left top, Baseline—interstitial lung disease with focal changes right. Right top, New patchy focal unilateral abnormalities and small pleural effusion—4 weeks. Left bottom, Extensive infiltrates (pattern D)—8 weeks. Right bottom, Marked improvement with discontinuation of everolimus therapy drug held and antibiotic treatment—12 weeks (Supplement: case 5). Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20b1) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Possible case. Left, Baseline—interstitial lung disease (pattern E) possibly from prior radiation. Right, More extensive focal interstitial changes (pattern E) at 4 weeks (Supplement: case 9). Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ba20b1) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001)  Dorothy A. White, MD, Lawrence."

Similar presentations


Ads by Google